New registry to track ion beam therapy outcomes in 2,800 cancer patients

NCT ID NCT03049072

Recruiting now Knowledge-focused Sponsor: EBG MedAustron GmbH Source: ClinicalTrials.gov ↗

First seen Mar 25, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This study is a registry that collects information from about 2,800 tumor patients treated with ion beam therapy at MedAustron. The goal is to track how well the therapy works and what side effects occur. Researchers will measure tumor response, survival, and quality of life over time. The study does not test a new treatment but gathers real-world data to improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ION BEAM RADIATION THERAPY FOR TUMOR PATIENTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

EBG MedAustron GmbH
RECRUITING

Wiener Neustadt, Lower Austria, 2700, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ION BEAM RADIATION THERAPY FOR TUMOR PATIENTS